Byrna Technologies Inc. annual report, FY2012

Business context and reporting period

This summary covers Security Devices International, Inc. (SDI), a development-stage less-lethal ammunition company, for the fiscal year ended November 30, 2012, including the quarter ended that date. The filing does not identify Byrna Technologies Inc.; confirm that the filing matches the requested issuer.

SDI developed the 40mm blunt impact projectile (BIP) and previously worked on a wireless electric projectile (WEP), whose development it discontinued in 2011. BIP research and development was completed in summer 2012; the company reported successful testing, Chemring ammunition certification, and receipt of a U.S. Department of Transportation number required for shipping. SDI had no product revenue during the year.

Financial results and liquidity

MetricFY 2012FY 2011
Revenue$0$0
Operating expenses$1,862,438$831,280
Net loss$2,019,938$901,558
Basic and diluted loss per share$0.07$0.03
Cash used in operations$1,294,895$1,170,821
Cash at year-end$232,471$114,835

Gross profit and operating margins are not meaningful because SDI reported no revenue. Fourth-quarter 2012 net loss was $1,068,668, compared with $203,747 in the fourth quarter of 2011; fourth-quarter revenue was nil in both periods.

At November 30, 2012, current assets were $272,171 and current liabilities were $150,368, giving working capital of $121,803, versus a $471,538 working-capital deficit a year earlier. Total assets were $417,219; total liabilities were $1,343,007, including $1,192,639 of convertible debentures. Shareholders’ deficit was $925,788. The filing gives no clear debt-maturity schedule that is consistent across the debenture disclosures.

Financing activities provided $1,559,750 in 2012: $649,750 from common-share issuance and $910,000 from convertible debentures. Investing activities used $147,219, primarily for molds. The company reported no off-balance-sheet arrangements.

Changes versus the prior year

  • Net loss more than doubled, while general and administrative expense increased by $1,432,451 to $2,056,996.
  • The 2012 loss included $929,365 of non-cash stock-based compensation; the fourth-quarter loss included $640,912 of that expense.
  • Research and product development showed a $215,143 recovery in 2012, rather than expense, following settlement of a former contractor’s $315,143 payable for a $100,000 payment.
  • Working capital improved through equity and debt financing, although operating cash use remained substantial.
  • Common shares outstanding rose from 26,828,050 at November 30, 2011 to 31,472,433 at November 30, 2012. The filing reports 33,273,913 shares outstanding as of February 15, 2013.

Outlook, risks and unusual items

Management expected losses to continue and stated that additional capital was needed to fund operations, product launch, and liabilities. The auditor’s report highlighted substantial doubt about SDI’s ability to continue as a going concern; the audited statements were not adjusted for that uncertainty. No revenue or earnings guidance was provided.

Management planned to develop five BIP variants—four payload rounds and a lower-cost practice round—with a target completion in the second quarter of calendar 2013. Chemring had a five-year, non-exclusive worldwide marketing and sales arrangement; a separate five-year supply and manufacturing agreement made SDI dependent on its manufacturer. Sales remain subject to customer adoption, competition, export and other regulation, required approvals, and product-liability and safety risks.

Subsequent financing disclosures include a CDN $200,000 working-capital loan dated January 30, 2013, bearing 6% interest and repayable on demand or by July 30, 2013, plus bonus warrants. SDI also filed a preliminary Canadian prospectus on February 21, 2013, seeking CDN $3,000,000 in gross proceeds; this was a proposed offering, not reported as completed. The filing describes significant related-party compensation and equity awards, including options and warrants issued to directors, officers, and affiliated entities.

Management assessed disclosure controls and internal control over financial reporting as effective, while noting that limited accounting staff prevented full segregation of duties. The independent auditor expressed an unqualified opinion on the financial statements but did not audit internal control effectiveness.

Important facts for investors to verify

  • Confirm issuer identity: the filing is for Security Devices International, Inc., not Byrna Technologies Inc.
  • Verify the status and commercial progress of BIP sales, the Chemring relationship, manufacturing readiness, and the planned product variants; the filing reports no sales.
  • Assess financing runway and terms, including the proposed CDN $3 million offering, the short-term CDN $200,000 loan, and the outstanding convertible debentures.
  • Reconcile debenture maturity disclosures: the balance-sheet schedule states maturities in 2014 and 2015, while portions of the note text state January 16, 2012.
  • Verify the date of the disclosed $500,000 debt conversion: the subsequent-events note says January 23, 2012, a date preceding the November 30, 2012 year-end.
  • Consider dilution from issued shares, convertible debt, and outstanding options and warrants; the filing reports 1,660,000 options and 4,319,000 warrants outstanding at year-end.